Acylglycerol kinase (AGK) activates the GSK3β S9 phosphorylation site via the PI3K/AKT pathway, leading to GSK3β inactivation, β-catenin stabilization, and subsequent promotion of RCC growth and metastasis (Zhu et al., 2020). Here, AKT1 is linked to renal cell carcinoma.